People who are most vulnerable to #HIV, including transgender women, often face difficult barriers to accessing prevention and care, including stigma and discrimination. Help replace stigma with science by spreading facts about HIV. Watch this video with Blossom from the Los Angeles LGBT Center and talk to a healthcare provider for more information on your sexual health: http://glassdoor.com/slink.htm?key=vM4lX. #SpreadFactsNotFear
The increasing availability of effective #HIV treatments within low and middle-income countries has produced encouraging signs of progress, yet there is more work to be done to fight the epidemic. Our VP of Access Operations and Emerging Markets, Papa Salif Sow, expands on this global-scale effort to improve access in this month’s issue of New Scientist: http://glassdoor.com/slink.htm?key=vQwXY.
People living with HIV can now live longer, fuller lives thanks to a series of biomedical breakthroughs and the dedication of thousands of researchers around the world. Learn more about 30 years of progress in HIV treatment from our Medical Director, Peter Borg, in the most recent issue of New Scientist: http://glassdoor.com/slink.htm?key=vQNTY.
More than 12,000 people in Alabama were living with HIV in 2014. Douglas Brooks, our Senior Director for Community Engagement, and Nic Carlisle of the Southern AIDS Coalition highlight a new partnership with the Southern HIV/AIDS Strategy Initiative at Duke University as part of the Gilead COMPASS Initiative™ Corporate Giving Program which aims to combat the HIV/AIDS epidemic in Birmingham, AL and across the Southern U.S. Read more at http://glassdoor.com/slink.htm?key=vQsIV: http://glassdoor.com/slink.htm?key=vQsIz.
We at Gilead Sciences support our colleagues at Kite Pharma and their dedication to driving cancer research that has the potential to improve the lives of people living with the disease around the world. #WorldCancerDay
CAR T cell immunotherapy named the Advance of the Year in annual ASCO report. We’re proud to play a role in advancing cell therapy: http://glassdoor.com/slink.htm?key=vQssI
We’re proud to join more than 500 organizations in support of the U=U Consensus Statement. Learn more about the U=U campaign and the full Consensus Statement: http://glassdoor.com/slink.htm?key=vQU39.
Throughout 2018 we will be sharing a quick glimpse into our working lives here at Gilead. Meet Lauryn from the Regulatory Affairs team in Foster City http://glassdoor.com/slink.htm?key=vQUsw . #gileadlife
Gilead's subsidiary Kite announces clinical collaboration with Pfizer to evaluate investigational treatment combination in large B-cell lymphoma. Find out more: http://glassdoor.com/slink.htm?key=vQUHU
Throughout 2018 we will be sharing a quick glimpse into our working lives here at Gilead. Please meet Ligia from the Biometrics team in Foster City. #gileadlife http://glassdoor.com/slink.htm?key=vQgIa